Skip to content

Vera Therapeutics VERA Change in Other Assets

Change in Other Assets at other companies

Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
$6.38M+282%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
-$949K-116%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
-$1.3M-767%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$1.05M+1,152%
Alumis Inc. logo
Alumis Inc.ALMS
$545K+1,334%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$1.7M-50.5%

Other financials

Income statement

See full
Operating income-$125.1M-119%
Net income-$121.0M-134%
EPS (diluted)-$1.69-109%

Balance sheet

See full
Cash & equivalents$114.4M+108%
Total debt$75.0M+37.8%
Total equity$499.7M-6.6%
Total assets$621.7M+1.9%

Cash flow

See full
Operating cash flow-$106.5M-95.8%
CapEx$23.0K-87.7%
Free cash flow-$106.5M-95.1%

Valuation

See full
Market cap$2.74B+87.5%
Enterprise value$2.7B+85.0%

Returns & leverage

See full
Return on equity-71.3%+296pp
Debt / equity0.2×0.0×
Current ratio13.6×-14.0×

Where this comes from

Reported directly by Vera Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.

The official record: Vera Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vera Therapeutics's change in other assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vera Therapeutics's change in other assets?
Vera Therapeutics (VERA) reported change in other assets of $5.14M in Q1 2026.
How has Vera Therapeutics's change in other assets changed year-over-year?
Vera Therapeutics's change in other assets decreased by 12.5% year-over-year, from $5.88M to $5.14M.
What does change in other assets mean?
Change in miscellaneous assets affecting operating cash flow.